Marshall Wace North America’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-86,954
Closed -$2M 1824
2021
Q2
$2M Sell
86,954
-215,143
-71% -$4.95M 0.01% 804
2021
Q1
$6.67M Sell
302,097
-6,784,335
-96% -$157M 0.03% 491
2020
Q4
$132M Buy
7,086,432
+1,784,910
+34% +$29.3M 0.59% 30
2020
Q3
$76.9M Buy
5,301,522
+1,794,459
+51% +$22.8M 0.49% 43
2020
Q2
$39.3M Buy
3,507,063
+1,197,662
+52% +$13.5M 0.26% 100
2020
Q1
$23.1M Buy
+2,309,401
New +$32.3M 0.17% 143
2019
Q4
Sell
-377,752
Closed -$4.56M 1705
2019
Q3
$4.56M Sell
377,752
-821,748
-69% -$11.3M 0.03% 378
2019
Q2
$17.5M Buy
+1,199,500
New +$17.8M 0.11% 163

Other funds holding CHNG

Marshall Wace North America's CHNG Position: Q3 2021 in Review

Marshall Wace North America sold out of Change Healthcare Inc. Common Stock (CHNG) in Q3 2021, closing a stake of 86,954 shares — an estimated $2M sold.

Marshall Wace North America first reported a position in CHNG in Q2 2019 and held it in 8 quarters. The position peaked at $132M in Q4 2020. 279 funds tracked by Wall St. Rank hold CHNG as of Q3 2021.

  • Marshall Wace North America reported no remaining Change Healthcare Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 86,954 Change Healthcare Inc. Common Stock shares in Q3 2021, an estimated $2M.
  • Marshall Wace North America first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Marshall Wace North America's Change Healthcare Inc. Common Stock position peaked at $132M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.